Roselabs Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Roselabs Finance Ltd has informed BSE that its Board of Directors will meet on January 20, 2026 to consider and approve the unaudited financial results along with the Limited Review Report for the quarter and nine months ended December 31, 2025. The company has also confirmed that the trading window for dealing in its shares has been closed from January 1, 2026 until 48 hours after the results are declared, in line with insider trading rules. This is a routine compliance filing under SEBI LODR Regulation 29, and no financial figures or specifics have been disclosed at this stage.
This is a standard pre-results intimation and does not contain any financial data. Investors should wait for the actual Q3 results on or after January 20, 2026 to assess any impact on the stock. The trading window closure means insiders cannot trade until results are announced.